Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

pomalidomide

pomalidomide
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Pomalyst CAPSULE, ORAL 1 mg, 2 mg, 3 mg, 4 mg      
Comments:

At Huntsville Main/W&C/Madison, orders for this medication should be rejected and reviewed by an oncology clinical specialist or an oncology pool member (see second page of the document "Hormone Therapies and Guidance on Oral Chemotherapy") 

Pomalyst medication guide

POMALYST is classified as non-formulary, not stocked. It is distributed exclusively through specialty pharmacies and is not available for procurement by HH pharmacy. The patient may use his/her own supply if needed during admission. Initiation should be deferred to the outpatient setting.

Reviewed: April 23, 2013 (Pomalyst)

REMS (Pomalyst): View FDA REMS Info

Last updated: Mar. 5, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved